Statistics about Health, Pharma & Medtech in United States
Statistics
- Oncternal Therapeutics, Inc. net income 2019-2023
- Olema Pharmaceuticals net income 2019-2023
- Bridgebio Pharma net income 2019-2023
- Elutia operating profit 2019-2023
- Nrx Pharmaceuticals operating profit 2019-2023
- Bridgebio Pharma net cash 2019-2023
- Relay Therapeutics total assets 2019-2023
- Dyne Therapeutics operating profit 2019-2023
- Oncocyte total assets 2019-2023
- Tenaya Therapeutics net cash 2020-2023
- Ocuphire Pharma, Inc. liabilities 2019-2023
- Dermata Therapeutics liabilities 2020-2023
- Dermata Therapeutics operating profit 2020-2023
- Beam Therapeutics total assets 2019-2023
- Dermata Therapeutics total assets 2020-2023
- Burzynski Research Institute liabilities 2019-2023
- Regen Biopharma total equity 2019-2023
- Dermata Therapeutics net cash 2020-2023
- Odonate Therapeutics, Inc. liabilities 2017-2020
- Oncocyte liabilities 2019-2023
- Burzynski Research Institute net cash 2019-2023
- Relay Therapeutics liabilities 2019-2023
- Dermata Therapeutics total equity 2019-2023
- Ocugen liabilities 2019-2023
- Odonate Therapeutics, Inc. operating profit 2017-2020
- Coherus Biosciences net income 2019-2023
- Avenir Wellness Solutions total equity 2019-2023
- Burzynski Research Institute net income 2022-2023
- Tango Therapeutics, Inc. net cash 2020-2023
- Oncocyte operating profit 2019-2023
- Ocuphire Pharma, Inc. operating profit 2019-2023
- Coherus Biosciences operating profit 2019-2023
- Coherus Biosciences revenue 2019-2023
- Tonix Pharmaceuticals Holding net cash 2019-2023
- Beam Therapeutics revenue 2019-2023
- Oncternal Therapeutics, Inc. revenue 2019-2023
- Ocuphire Pharma, Inc. total assets 2019-2023
- Novan operating profit 2018-2022
- Thorne Healthtech net cash 2020-2022
- Regen Biopharma net cash 2019-2023
- Beam Therapeutics liabilities 2019-2023
- Bio-Techne Corp revenue 2020-2024
- Ocugen total assets 2019-2023
- Avidity Biosciences total assets 2019-2023
- Beam Therapeutics net income 2019-2023
- Avidity Biosciences total equity 2019-2023
- Bio-Techne Corp net income 2020-2024
- Odonate Therapeutics, Inc. net cash 2017-2020
- Beam Therapeutics net cash 2019-2023
- Avidity Biosciences net cash 2019-2023
- Beam Therapeutics total equity 2019-2023
- Burzynski Research Institute operating profit 2019-2023
- Burzynski Research Institute total equity 2019-2023
- Avidity Biosciences liabilities 2019-2023
- Avidity Biosciences net income 2019-2023
- Avidity Biosciences revenue 2019-2023
- Renovorx total assets 2020-2023
- Oncocyte net cash 2019-2023
- Avidity Biosciences operating profit 2019-2023
- Renovorx liabilities 2020-2023
- Ocuphire Pharma, Inc. net cash 2019-2023
- Ocugen net cash 2019-2023
- Biodelivery Sciences International Inc operating profit 2017-2021
- Aligos Therapeutics total assets 2019-2023
- Brainstorm Cell Therapeutics net cash 2019-2023
- Ocean Biomedical, Inc. liabilities 2021-2022
- Bellerophon Therapeutics net cash 2018-2022
- Novaccess Global total equity 2019-2023
- Novaccess Global net cash 2019-2023
- Novaccess Global total assets 2019-2023
- Regen Biopharma revenue 2019-2023
- Oncosec Medical total equity 2018-2022
- Regulus Therapeutics revenue 2017-2021
- Oruka Therapeutics, Inc. operating profit 2019-2023
- Biomea Fusion total assets 2020-2023
- Oruka Therapeutics, Inc. total assets 2019-2023
- Oruka Therapeutics, Inc. net cash 2019-2023
- Oruka Therapeutics, Inc. liabilities 2019-2023
- Oruka Therapeutics, Inc. total equity 2019-2023
- Relay Therapeutics revenue 2020-2023
- Ocean Biomedical, Inc. total equity 2021-2022
- Comera Life Sciences Holdings, Inc. total equity 2019-2022
- Biomea Fusion net income 2019-2023
- Comera Life Sciences Holdings, Inc. net cash 2020-2022
- Biomea Fusion total equity 2019-2023
- Biodesix net cash 2019-2023
- Renovacor, Inc. net cash 2019-2021
- Omeros total equity 2019-2023
- Ayala Pharmaceuticals revenue 2019-2022
- Biomea Fusion net cash 2019-2023
- Compass Therapeutics liabilities 2019-2023
- Biomea Fusion operating profit 2019-2023
- Trex Wind-Down, Inc. total assets 2018-2022
- Compass Therapeutics total assets 2019-2023
- Biomea Fusion liabilities 2020-2023
- Tango Therapeutics, Inc. total assets 2020-2023
- Ayala Pharmaceuticals net income 2019-2021
- Replimune Group total equity 2019-2023
- Novaccess Global revenue 2018-2023
- Tonix Pharmaceuticals Holding total assets 2019-2023